News EVERSANA builds its AI Agency with Estima acquisition EVERSANA has acquired UK AI-powered health economics and outcomes research (HEOR) firm Estima to help its customers "modernise commercialisation."
Sales & Marketing One year later, EVERSANA plans to go beyond the AI agency At an event in New York City, EVERSANA shared updates, customer perspectives, and future plans for its AI agency, which is moving beyond that mandate.
News Lundbeck taps EVERSANA’s AI Agency for commercialisation In advance of its NYC event, EVERSANA announces expanded AI agency capabilities and a partnership with brain health giant Lundbeck.
Market Access A dynamic moment for pharma pricing: Insights from PPIC At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.
News Jen Norton appointed market access leader at EVERSANA EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.
News Mike Guarino appointed to lead EVERSANA INTOUCH Life sciences service provider EVERSANA has named industry veteran Mike Guarino to lead its global health agency EVERSANA INTOUCH.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.